No-touch graft harvesting shows no advantage over conventional technique in CABG

No-touch graft harvesting did not appear to be beneficial compared with the conventional technique for coronary artery bypass grafting (CABG), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

BMS licenses TCR-T immunotherapy therapy from Immatics – Pharmaceutical Technology

Headquarters of Bristol-Myers Squibb (BMS) Germany in Munich, Germany. BMS has exercised opt-in rights for a new TCR-T therapy from Immatics. Credit: Shutterstock/nitpicker Bristol Myers

May 2, 2023

Researchers investigate the association between low fertility and uterine microbiota in dairy cows

Reduced fertility prolongs the interval from calving to conception in dairy cows, resulting in significant economic losses to dairy farms.

July 7, 2023

Sanofi CEO Paul Hudson pitches 12 blockbusters in a bid to convince investors on boosting R&D spend

Four years ago, Paul Hudson welcomed investors and analysts to Sanofi’s Cambridge, MA office, introducing his strategy for the French pharma giant. Hudson, who joined

December 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.